62 replies to this topic

[Rich C]

Q3 GDP came in up 33.1%, in line with the Atlanta Fed estimate from last month.  That is an annualized number so we were up 8% for the quarter, cancelling the poor showing in Q2.  Earnings came in better than the Factset estimate for Q3, down only 7% vs. 2019, but still a poor number.  The trailing 12 month GAAP PE on the S&P rose again to 36, with the latest quarter being Q3 (92% of stocks reported).  Factset projects earnings in Q4 to be 14% below the year prior quarter, still poor.  There was almost no movement in the bond market over the month, and bonds are no alternative to stocks.  The banks rallied again this month on the announcement of two viable COVID 19 vaccines, so there is an end in sight to mortgage forbearance.

 

But, the COVID virus fall wave continues to ramp up, cities and states are restricting peoples movement to slow the virus, and that will harm the recovery in Q4.  The election is settled for all practical purposes.

 

The bull market continues, but the valuation is dangerously high and with COVID 19 on the rampage, a correction could be near.

[Rich C]

The second estimate of Q3 GDP was unchanged at +33%, while the latest GDPNow estimate from the Atlanta Fed for Q4 GDP is +11%, which is an annualized number and a healthy one.  The Fed remains on hold with interest rates while they suggest the govt. needs to step up with fiscal stimulus.  The trailing 12 month GAAP PE on the S&P is 37 times earnings, up again from last month.  Factset projects that Q4 S&P earnings will be 10% lower than 2019, an improvement over last month's projection of 14% lower.  Following the bank stress tests, the Fed announced Friday that the big banks can begin stock buybacks in 2021 if their earnings allow it, which is good news in the important banking sector.

 

Covid 19 is raging in many areas of the US, with ICU beds full in a few locations and near full in many more.  The vaccine is just beginning to roll out, but it appears we are at least two months until an appreciable affect will be seen, based on the number of people who have received it.

 

The bull market continues, but the valuation is dangerously high and with COVID 19 on the rampage, there is significant risk in this market.

[Rich C]

The third estimate of Q3 GDP was +33.4.  GDPNow estimates Q4 GDP to be +9% annualized rate.  The Fed is on hold, but the market is pushing up longer term rates with the 10 year Treasury at 1.1%.  Rates are rising based on the Covid vaccine rollout and expectations of improved economic activity in 2021, and dollar weakness.  The trailing 12 month GAAP PE on the S&P is 34:1, so it remains richly valued.  The rich valuation has been justified by the low rates, but as rates rise and higher rates are plugged into investors "discounted cash flow" models, the multiple will eventually need to shrink, or earnings will have to rise significantly.  S&P earnings for Q4 are projected to be 9% below the 2019 level, but Q1 earnings should show a mid-teens increase over a weak 2020 level.

 

Covid is raging across the US and that should be a headwind to growth in Q1.

 

The bull market continues, but valuation and the virus pose risks to the market.